Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapy.

Blood Cancer J · 2024 · PMC11405931 · PMID 39284846

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

borderline significancep = 0.055so close (0.05 < p ≤ 0.1)

Multivariate analysis within the ELN risk groups confirmed t-AML to be no independent risk factor for OS, RR and NRM, although there was borderline significance for inferior OS of t-AML patients within the intermediate I/II risk group ( p = 0.055, Supplementary Fig. 1 ).

also in 4,352 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.